TDC
SLXP

Thompson Davis & Co’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Thompson Davis & Co’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,915
Closed -$299K – 1365
2014
Q3 		$299K Buy
+1,915
New +$299K 0.39% 55
2014
Q1 		– Sell
-2,000
Closed -$180K – 928
2013
Q4 		$180K Buy
+2,000
New +$180K 0.27% 87